BIIB – Biogen Inc.

Stock Forums Stocks Forum Nasdaq Stocks BIIB – Biogen Inc.

Tagged: ,

This topic contains 3 replies, has 1 voice, and was last updated by Stocks News Feed 2 months ago.

Viewing 3 replies - 1 through 3 (of 3 total)
  • Author
  • #298030

    BIIBBiogen reached an agreement to sell its spinal muscle atrophy treatment Spinraza to England’s National Health Service for an undisclosed price. Spinraza has a U.S. list price of $750,000 for the first year and $375,000 per year in subsequent years.


    BIIB – Biogen announces $5 billion buyback days after shelving Alzheimer’s trials — CNBC


    BIIB: Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease

Viewing 3 replies - 1 through 3 (of 3 total)

You must be logged in to reply to this topic. Login Register

Done Reading? You might also find these links useful:
Stock Market News | Social Activity Stream | Stock Forums